Sell Strides Pharma Science, target Rs 405: Manas Jaiswal
Sell Strides Pharma Science at a price target of Rs 405 and a stop loss at Rs 451 from the entry point.
By ETMarkets.com |
ThinkStock Photos
Manas Jaiswal of manasjaiswal.com has a sell call on Strides Pharma Science with a target price of Rs 405.
The current market price of Strides Pharma Science is Rs 434.10.
Time period given by the analyst is Intra Day when Strides Pharma Science price can reach the defined target.
Manas Jaiswal recommended keeping a stop loss at Rs 451.
Strides Pharma Science, incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3,887.32 Crore) operating in Pharmaceuticals and health care sector.
The company’s top management includes Mr.Arun Kumar, Mr.Badree Komandur, Mr.Bharat D Shah, Mr.Deepak Vaidya, Mr.Homi Rustam Khusrokhan, Mr.S Sridhar, Ms.Sangita Reddy.
Company has BSR & Co. LLP as its auditors.
As on 30-06-2018, the company has a total of 89,548,913 shares outstanding.
The current market price of Strides Pharma Science is Rs 434.10.
Time period given by the analyst is Intra Day when Strides Pharma Science price can reach the defined target.
Manas Jaiswal recommended keeping a stop loss at Rs 451.
Strides Pharma Science, incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3,887.32 Crore) operating in Pharmaceuticals and health care sector.
The company’s top management includes Mr.Arun Kumar, Mr.Badree Komandur, Mr.Bharat D Shah, Mr.Deepak Vaidya, Mr.Homi Rustam Khusrokhan, Mr.S Sridhar, Ms.Sangita Reddy.
ADVERTISEMENT
Company has BSR & Co. LLP as its auditors.
As on 30-06-2018, the company has a total of 89,548,913 shares outstanding.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
